Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system

Vox Sanguinis

Volumn 106, Issue 1, 2014, Pages 38-44

  Plaza, E M ^a   Cespedes P ^a   Fernandez H ^a   Sanchez Guiu M I ^a   Egea, J M ^b   Vicente, V ^a   Lozano, M L ^a   Rivera, J ^a  

^a HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

ORBISAC; Platelet concentrates; RANTES; SCD62P; SCL40L; TACSI

Indexed keywords

BICARBONATE; BUFFY COAT DERIVED PLATELET CONCENTRATE; CD40 LIGAND; GLUCOSE; LACTIC ACID; PADGEM PROTEIN; RANTES; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LEUKOPENIA; PH; PRIORITY JOURNAL; QUALITY CONTROL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION;

ORBISAC; PLATELET CONCENTRATES; RANTES; SCD62P; SCL40L; TACSI;

BLOOD BUFFY COAT; BLOOD PLATELETS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; PLASMA; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; PLATELETPHERESIS;

EID: 84890785990     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12072     Document Type: Article

References (28)

1. Heal JM, Blumberg N: Optimizing platelet transfusion therapy. Blood Rev 2004; 18:149-165
2. Vassallo RR, Murphy S: A critical comparison of platelet preparation methods. Curr Opin Hematol 2006; 13:323-330
3. Lozano ML, Rivera J, Vicente V: Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use? Med Clin (Barc) 2012; 138:528-533
4. Lozano M, Estebanell E, Cid J, et al.: Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion 1999; 39:951-959
5. Anderson NA, Gray S, Copplestone JA, et al.: A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med 1997; 7:33-39
6. Pietersz RN, Reesink HW, Dekker WJ, et al.: Preparation of leukocyte-poor platelet concentrates from buffy coats. I. Special inserts for centrifuge cups. Vox Sang 1987; 53:203-207
7. Gulliksson H, Sjödin A, Sandgren P, et al.: Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system. Transfus Apher Sci 2003; 29:11-12
8. Janetzko K, Klüter H, van Waeg G, et al.: Fully automated processing of buffy-coat-derived pooled platelet concentrates. Transfusion 2004; 44:1052-1058
9. Rivera J, Lozano ML, Vicente V: In vitro changes of platelet parameters: lessons from blood banking. Methods Mol Biol 2004; 273:57-72
10. Thon JN, Schubert P, Devine DV: Platelet storage lesion: a new understanding from a proteomic perspective. Transfus Med Rev 2008; 22:268-279
11. Larsson S, Sandgren P, Sjödin A, et al.: Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion 2005; 45:743-751
12. Larrea González L, Ortiz de Salazar MI, Roig R, et al.: Platelet activation during storage of platelet concentrates processed from buffy coats by the automated OrbiSac system. Transfusion 2007; 47:1555-1556
13. Vetlesen A, Mirlashari MR, Ezligini F, et al.: Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007; 47:126-132
14. Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, et al.: Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates. Transfusion 2008; 48:2114-2121
15. Cid J, Ramiro L, Escoda L, et al.: Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval. Vox Sang 2009; 96:29-33
16. Plaza EM, Lozano ML, Guiu IS, et al.: Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system. Blood Transfus 2012; 10:480-489
17. Sandgren P, Hild M, Sjödin A, et al.: Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability. Vox Sang 2010; 99:341-347
18. Chicchi R, Biguzzi R, Santarelli R: The OrbiSac system: results and organizational impact. Blood Transfus 2007; 5:15-19
19. Cid J: Automation in blood component preparation methods; in: Blajchman M, Cid J, Lozano M (eds): Blood Component Preparation: From Benchtop to Bedside. Bethesda, AABB Press, 2011:271-286
20. Larrea L, Ortiz de Salazar MI, Roig R, et al.: Fully automated processing of buffy coat-derived pooled concentrates. Transfusion 2005; 45:642-643
21. Council of Europe-European Directorate for the Quality of Medicines & HealthCare (EDQM). Guide to the Preparation, Use and Quality Assurance of Blood Components. (16th edn). ISBN 978-92-871-7022-4. Strasbourg, France, Council of Europe Pub, 2011
22. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, et al.: Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996; 76:1086-1089
23. Kyrle PA, Hron G, Eichinger S, et al.: Circulating p-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 2007; 97:880-883
24. Wakamoto S, Fujihara M, Kuzuma K, et al.: Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003; 43:1038-1046
25. Klüter H, Bubel S, Kirchner H, et al.: Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39:1179-1184
26. Blumberg N, Spinelli SL, Francis CW, et al.: The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res 2009; 45:251-260
27. Kaufman J, Spinelli SL, Schultz E, et al.: Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 2007; 5:788-796
28. Khan SY, Kelher MR, Heal JM, et al.: Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108:2455-2462